Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture

Phosphorylation-Regulated Degradation of the Tumor-Suppressor Form of PED by Chaperone-Mediated Autophagy in Lung Cancer Cells

(2014) Cristina Quintavalle et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Persistent Hepatitis C Virus Infection Impairs Ribavirin Antiviral Activity through Clathrin-Mediated Trafficking of Equilibrative Nucleoside Transporter 1

(2014) Rajesh Panigrahi et al.   JOURNAL OF VIROLOGY

Impaired Expression of Type I and Type II Interferon Receptors in HCV-Associated Chronic Liver Disease and Liver Cirrhosis

(2014) Partha K. Chandra et al.   PLoS One

Interferon-Combination Strategies for the Treatment of Chronic Hepatitis C

(2014) Donald Jensen et al.   SEMINARS IN LIVER DISEASE

HCV Infection Selectively Impairs Type I but Not Type III IFN Signaling

(2013) Partha K. Chandra et al.   AMERICAN JOURNAL OF PATHOLOGY

Impaired autophagy response in human hepatocellular carcinoma

(2013) Lili Bao et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Triple therapy with boceprevir or telaprevir for prior HCV non-responders

(2012) Tarik Asselah   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Elevated lipogenesis and diminished cholesterol synthesis in patients with hepatitis C viral infection compared to healthy humans

(2012) Jennifer E. Lambert et al.   HEPATOLOGY

Interferon-lambda (IFN- ) induces signal transduction and gene expression in human hepatocytes, but not in lymphocytes or monocytes

(2012) H. Dickensheets et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Liver X receptor α-mediated regulation of lipogenesis by core and NS5A proteins contributes to HCV-induced liver steatosis and HCV replication

(2012) María Victoria García-Mediavilla et al.   LABORATORY INVESTIGATION

Free fatty acids induce ER stress and block antiviral activity of interferon alpha against hepatitis C virus in cell culture

(2012) Feyza Gunduz et al.   Virology Journal

Impact of HCV genetic differences on pathobiology of disease

(2011) Maria Ripoli et al.   Expert Review of Anti-Infective Therapy

Steatosis is the predictor of relapse in HCV genotype 3- but not 2-infected patients treated with 12 weeks of pegylated interferon-α-2a plus ribavirin and RVR

(2011) L. Restivo et al.   JOURNAL OF VIRAL HEPATITIS

Triple therapy with telaprevir: results in hepatitis C virus-genotype 1 infected relapsers and non-responders

(2011) Nicole Forestier et al.   LIVER INTERNATIONAL

Telaprevir for Retreatment of HCV Infection

(2011) Stefan Zeuzem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Unique ties between hepatitis C virus replication and intracellular lipids

(2011) Eva Herker et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Measuring antiviral activity of benzimidazole molecules that alter IRES RNA structure with an infectious hepatitis C virus chimera expressing Renilla luciferase

(2010) Shuanghu Liu et al.   ANTIVIRAL RESEARCH

IL-7 induces rapid clathrin-mediated internalization and JAK3-dependent degradation of IL-7R  in T cells

(2010) C. M. Henriques et al.   BLOOD

Abnormalities of lipid metabolism in hepatitis C virus infection

(2010) F. Negro   GUT

IL28B inhibits hepatitis C virus replication through the JAK–STAT pathway

(2010) Leiliang Zhang et al.   JOURNAL OF HEPATOLOGY

Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin

(2010) Tarik Asselah et al.   LIVER INTERNATIONAL

Virus-Induced Unfolded Protein Response Attenuates Antiviral Defenses via Phosphorylation-Dependent Degradation of the Type I Interferon Receptor

(2009) Jianghuai Liu et al.   Cell Host & Microbe

Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C

(2009) F. Negro et al.   JOURNAL OF VIRAL HEPATITIS

The global burden of hepatitis C

(2009) Daniel Lavanchy   LIVER INTERNATIONAL

Hepatitis C virus hijacks host lipid metabolism

(2009) Gulam H. Syed et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM